Trump budget would limit NIH grant recipients' spending on admin, IT

A cap could be placed on what “indirect” medical research costs can be covered by National Institutes of Health (NIH) grants, which researchers warn could “disembowel” their institutions.

As reported by The Atlantic, the Trump administration’s full budget, due out next week, could include a 10 percent cap on overhead costs like administration, equipment, libraries, IT, lighting, heating, electricity. HHS Secretary Tom Price, MD, has said such costs are evidence of “inefficiencies” in NIH, with some universities spending up to 85 percent of their grants on those costs, which are negotiated with the agency.

Those in the research field, however, say many of the costs aren’t optional and grants don’t always fund what it takes to keep labs and research facilities running.

“We could find efficiencies,” said Mary Woolley, president of Research!America, a non-profit that advocates for biomedical research, “but you’re not looking for efficiencies when you say we’ll cut off three or four of your appendages.”

Read the full article at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup